首页 > 市场调查报告书 > 医疗设备

e保健

市场调查报告书

商品编码

1606519

全球远距病患监护市场 - 2024-2031

Global Remote Patient Monitoring Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球远距病患监护市场规模达到502亿美元，预计到2031年将达到2,510亿美元，2024-2031年预测期间复合年增长率为22.4%。

远端患者监测是指使用数位技术、医疗设备和电信系统在传统临床环境之外（例如在家中或社区环境中）监测和管理患者的健康状况。远端患者监测涉及连续或定期收集与生命体征、症状或慢性病相关的患者资料，然后将其传输给医疗保健提供者进行审查、分析和后续护理。监控设备收集的资料透过安全的无线通讯技术传输到医疗保健提供者或监控平台。这些资料可以包括心率、血压、血糖值、氧饱和度等指标。

由于对高效慢性病管理的需求、全球向以患者为中心的护理模式的转变以及远端患者监测的日益普及，对远端患者监测的需求正在快速增长。例如，Vivalink 对美国各地医疗服务提供者的调查结果显示，84% 的受访者目前正在使用远距患者监护，并计划在2024 年增加其使用量。使用远距患者监护。

市场动态：

驱动程式和限制

慢性病盛行率上升

慢性病盛行率的上升极大地推动了远距患者监护市场的成长，预计将在预测期内推动该市场的发展。慢性疾病通常需要定期监测关键生命体征，例如血压、血糖水平、心率和血氧饱和度。远端患者监测解决方案使患者能够在家中持续追踪自己的健康状况，并将资料传输给医疗保健提供者进行持续评估。

例如，根据国际糖尿病联盟 (IDF) 的数据，全球有超过 4.63 亿成年人患有糖尿病，对连续血糖监测 (CGM) 设备的需求正在飙升。 Dexcom 和 Abbott 等公司推出了 Dexcom G6 和 Freestyle Libre 等产品，广泛用于远端监测血糖水平。这些系统允许患者接收即时血糖读数并与医疗保健提供者共享资料，从而实现更有效的糖尿病管理。

据泛美卫生组织称，高血压影响着全球超过 30% 的成年人口，全球人口超过 10 亿。使用欧姆龙血压计等设备远端监测血压已变得越来越普遍。远端患者监测解决方案可以进行持续跟踪，帮助患者和医疗服务提供者更有效地管理疾病，避免中风或心臟衰竭等併发症。

心血管疾病是全球主要死亡原因，根据 CDC 的数据，每 33 秒就有一人死于心血管疾病。 2022年，702,880人死于心臟病。这相当于每 5 人死亡就有 1 人死亡。远端患者监测设备（例如用于连续心电图监测的 Medtronic 的 MiniMed 胰岛素帮浦和 iRhythm 的 Zio Patch）透过追踪关键指标并确保在需要时进行早期干预，有助于减少就诊次数。

缺乏患者的接受度和参与度

缺乏患者接受度和参与度是远距患者监护市场成长的重大障碍。虽然远距患者监测提供了许多好处，例如改善慢性病管理和降低医疗成本，但许多患者仍然难以完全接受这些技术。与此问题相关的主要挑战包括技术障碍、缺乏理解或意识以及隐私问题，所有这些都会影响患者的采用和参与。

许多患者，尤其是老年人，发现远距患者监护设备和健康平台难以使用。这些技术通常需要一定程度的数位素养，对于那些不熟悉数位工具的人来说，设定过程或持续使用可能看起来很复杂或令人沮丧。

例如，虽然远端健康监测越来越受欢迎，但作为远端患者监测的关键人群的老年患者可能会在采用新技术方面遇到困难。老年人缺乏舒适感和对科技的熟悉程度阻碍了其广泛采用，特别是在治疗心臟病和糖尿病等慢性疾病方面。

由于担心资料隐私和安全，患者可能会犹豫是否采用远距患者监护解决方案。透过网路传输敏感健康资料会引发与资料外洩、未经授权的存取或滥用个人健康资讯相关的问题。这些担忧可能会破坏信任并阻碍患者充分参与远距患者监护技术。

例如，根据 HIPAA 杂誌报导，2023 年 8 月，发现有 2,300 万笔医疗记录被洩露。在过去 12 个月中，平均每月有 9,989,003 笔医疗记录被洩露。截至 2024 年 8 月 31 日的一年内，已发生 491 起资料外洩事件，涉及 500 笔或更多记录，已知至少有 58,668,002 笔记录已外洩。目前，2024 年的平均外洩规模为 119,487 笔记录，中位外洩规模为 4,109 笔记录。

Remote patient monitoring refers to the use of digital technologies, medical devices and telecommunication systems to monitor and manage a patient's health outside of traditional clinical settings, such as at home or in a community setting. Remote patient monitoring involves the continuous or periodic collection of patient data related to vital signs, symptoms or chronic conditions, which is then transmitted to healthcare providers for review, analysis, and follow-up care. The data collected by the monitoring devices is transmitted via secure, wireless communication technologies to healthcare providers or monitoring platforms. The data can include metrics like heart rate, blood pressure, blood glucose levels, oxygen saturation and more.

The demand for remote patient monitoring is rapidly growing, driven by the need for efficient chronic disease management, the global shift toward more patient-centric care models and the rising adoption of remote patient monitoring. For instance, results of a Vivalink survey of providers across the U.S. revealed that 84% of the total respondents currently using remote patient monitoring and also plan to increase their usage in 2024. Additionally, according to Medscape, it is estimated that more than 60 million people in the U.S. will have used remote patient monitoring in 2024.

Market Dynamics: Drivers & Restraints

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases is significantly driving the growth of the remote patient monitoring market and is expected to drive the market over the forecast period. Chronic diseases often require regular monitoring of key vital signs, such as blood pressure, blood glucose levels, heart rate and oxygen saturation. Remote patient monitoring solutions enable patients to continuously track their health at home and transmit the data to healthcare providers for ongoing assessment.

For instance, with over 463 million adults worldwide living with diabetes, according to the International Diabetes Federation (IDF), the demand for continuous glucose monitoring (CGM) devices is soaring. Companies like Dexcom and Abbott have introduced products such as the Dexcom G6 and the Freestyle Libre, which are widely used for remote monitoring of glucose levels. These systems allow patients to receive real-time glucose readings and share data with healthcare providers, enabling more effective diabetes management.

According to the Pan American Health Organization, hypertension affects more than 30% of the adult population worldwide, more than one billion people around the world. Monitoring blood pressure remotely has become increasingly common with devices like Omron's Blood Pressure Monitor. Remote patient monitoring solutions allow for continuous tracking, which helps patients and providers manage the disease more effectively, avoiding complications like stroke or heart failure.

Cardiovascular diseases are the leading cause of death globally, according to the CDC, one person dies every 33 seconds from cardiovascular disease. In 2022, 702,880 people died from heart disease. That's the equivalent of 1 in every 5 deaths. Remote patient monitoring devices such as Medtronic's MiniMed insulin pumps and iRhythm's Zio Patch for continuous ECG monitoring help reduce hospital visits by tracking critical metrics and ensuring early intervention when needed.

Lack of patient acceptance and engagement

The lack of patient acceptance and engagement is a significant barrier to the growth of the remote patient monitoring market. While remote patient monitoring offers numerous benefits, such as improved chronic disease management and reduced healthcare costs, many patients still struggle to fully embrace these technologies. The key challenges related to this issue include technological barriers, lack of understanding or awareness and privacy concerns, all of which impact patient adoption and engagement.

Many patients, particularly older adults, find remote patient monitoring devices and health platforms difficult to use. These technologies often require a certain level of digital literacy, and for those who are not familiar with digital tools, the setup process or ongoing usage may seem complex or frustrating.

For instance, while remote health monitoring is gaining traction, older patients, who are a key demographic for remote patient monitoring, may struggle with adopting new technologies. This lack of comfort and technological familiarity among seniors hampers the widespread adoption, especially for managing chronic conditions like heart disease and diabetes.

Patients may be hesitant to adopt remote patient monitoring solutions due to concerns about data privacy and security. The transmission of sensitive health data over the internet raises issues related to data breaches, unauthorized access or misuse of personal health information. These concerns can undermine trust and discourage patients from fully engaging with remote patient monitoring technologies.

For instance, according to the HIPAA Journal, in August 2023, 23 million breached healthcare records are noticed. Over the past 12 months, an average of 9,989,003 healthcare records were breached each month. In the year to August 31, 2024, there have been 491 data breaches of 500 or more records, and at least 58,668,002 records are known to have been breached. The average breach size in 2024 is currently 119,487 records and the median breach size is 4,109 records.

Segment Analysis

The global remote patient monitoring market is segmented based on type, technology, application, end-user and region.

Type:

Wearable devices segment is expected to dominate the remote patient monitoring market share

The wearable devices segment is expected to dominate the global remote patient monitoring market due to their convenience, real-time data collection and continuous monitoring capabilities. Wearable devices are often the most user-friendly remote patient monitoring solutions, enabling patients to manage their health proactively while providing healthcare providers with consistent data for timely intervention.

Wearable devices are typically non-intrusive and easy to use, which makes them highly accessible to a wide range of patients. They allow for continuous monitoring of vital signs, such as heart rate, blood pressure, blood oxygen levels, and physical activity without the need for frequent hospital visits. For instance, Fitbit and Apple Watch are two widely used wearable devices that continuously track heart rate, steps and sleep patterns. These devices are designed to be worn throughout the day, giving users consistent feedback on their health while being minimally disruptive to their daily routine.

Wearables also help patients track their health, which motivates them to engage with their treatment plans. These devices often provide users with feedback, reminders and goals, fostering better self-management of chronic conditions and encouraging healthier behaviors. Thus, the market players are focusing on the development of remote patient monitoring devices with enhanced features.

For instance, in July 2024, Georgia-based KORE and Australian company mCare Digital launched a smartwatch for virtual patient monitoring called mCareWatch 241. The watch features an SOS setting that enables wearers to obtain emergency assistance, call capabilities, GPS tracking, reminders, a heart rate monitor, speed dialing, fall detection, a pedometer, a geo-fence alarm, non-movement detection and a mobile app and web dashboard.

Geographical Analysis

North America is expected to hold a significant position in the remote patient monitoring market share

North America is expected to hold the largest market share in the global remote patient monitoring market. North America, especially the United States, has a significant burden of chronic diseases such as diabetes, hypertension, heart disease and obesity, which drives the demand for remote monitoring solutions.

For instance, according to the CDC, an estimated 129 million people in the US have at least 1 major chronic disease (e.g., heart disease, cancer, diabetes, obesity, hypertension) as defined by the US Department of Health and Human Services. Remote patient monitoring helps manage these conditions by providing continuous monitoring, reducing hospital visits and enabling early interventions.

North America is a leader in digital health innovation, with widespread adoption of wearable devices, telehealth platforms and smart health technologies. This creates a favorable environment for remote patient monitoring solutions to thrive, as patients are increasingly willing to use technology to manage their health. For instance, the Apple Watch and Fitbit have become mainstream devices in North America, with features like heart rate monitoring, ECG and sleep tracking that are often used in conjunction with remote patient monitoring applications.

Asia-Pacific is growing at the fastest pace in the remote patient monitoring market

The Asia-Pacific region is experiencing the fastest growth in the remote patient monitoring market, owing to the strong presence of market players and innovative product launches, technological advancements and rising chronic disease prevalence. Asia Pacific especially India, Japan and China witnessed rapid growth in smartphone adoption, which has created a favorable environment for the use of wearables and mobile health applications. These technologies allow manufacturers to develop innovative wearable devices for remote patient monitoring.

For instance, Mindray launched the mWear system, an all-new wearable patient monitoring solution that enables an efficient workflow to continually monitor patient conditions and deliver advanced patient-centric care. mWearTM supports comprehensive and precise measurements of vital signs including ECG, oxygen saturation, noninvasive blood pressure, respiration rate, pulse rate and temperature.

Competitive Landscape

The major global players in the remote patient monitoring market include Apple Inc., Koninklijke Philips N.V., Samsung SDS America, Inc., Humworld Inc., Medtronic plc, Siemens Healthineers AG, GE HealthCare, Fitbit (Google), Abbott Laboratories, Qardio, Inc. and among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global remote patient monitoring market report delivers a detailed analysis with 70 key tables, more than 69 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Technology
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Lack of Patient Acceptance and Engagement
  - 4.1.1.2. Increasing number of organ transplants
- 4.1.2. Restraints
  - 4.1.2.1. Lack of Patient Acceptance and Engagement
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Wearable Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.2.3. Smartwatches and Fitness Trackers
- 6.2.4. Smart Clothing
- 6.2.5. Wearable ECG Monitors
- 6.2.6. Patches
- 6.2.7. Others
6.3. Non-Wearable Devices
- 6.3.1. Blood Pressure Monitors
- 6.3.2. Glucose Monitoring Devices
- 6.3.3. ECG Monitors
- 6.3.4. Pulse Oximeters
- 6.3.5. Thermometers
- 6.3.6. Others
6.4. Software Services

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Wearable Technology*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Bluetooth and Wi-Fi Technology
7.4. Artificial Intelligence (AI)
7.5. Mobile Health (mHealth)
7.6. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Chronic Disease Management*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Post-Operative Care
8.4. Maternal Health
8.5. Mental Health
8.6. Emergency Care
8.7. General Health and Wellness
8.8. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Homecare Settings
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Apple Inc.*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Koninklijke Philips N.V.
12.3. Samsung SDS America, Inc.
12.4. Humworld Inc.
12.5. Medtronic plc
12.6. Siemens Healthineers AG
12.7. GE HealthCare
12.8. Fitbit (Google)
12.9. Abbott Laboratories
12.10. Qardio, Inc.

LIST NOT EXHAUSTIVE